References
- Witting K, Santtila P, Rijsdijk F, et al. Correlated genetic and non-shared environmental influences account for the co-morbidity between female sexual dysfunctions. Psychol Med 2008; 26: 1–13
- Nobre P J, Pinto-Gouveia J. Emotions during sexual activity: differences between sexually functional and dysfunctional men and women. Arch Sex Behav 2006; 35: 491–499
- Yánez D, Castelo-Branco C, Hidalgo L A, Chedraui P A. Sexual dysfunction and related risk factors in a cohort of middle-aged Ecuadorian women. J Obstet Gynaecol 2006; 26: 682–686
- Gallicchio L, Schilling C, Tomic D, Miller S R, Zacur H, Flaws J A. Correlates of sexual functioning among mid-life women. Climacteric 2007; 10: 132–142
- Rosen R, Brown C, Heiman J, Leiblum S, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191–208
- Cohen B L, Barboglio P, Gousse A. The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. J Sex Med 2008; 5: 1418–1423
- Onem K, Erol B, Sanli O, et al. Is sexual dysfunction in women with obstructive sleep apnea-hypopnea syndrome associated with the severity of the disease? A pilot study. J Sex Med 2008; 5: 2600–2609
- Alder J, Zanetti R, Wight E, Urech C, Fink N, Bitzer J. Sexual dysfunction after premenopausal stage I and II breast cancer: do androgens play a role. J Sex Med 2008; 5: 1898–1906
- Berner M M, Hagen M, Kriston L. A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed. J Clin Psychiatry 2006; 67: 1649–1650
- Dennerstein L, Dudly E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause. Fertil Steril 2001; 76: 456–460
- Modelska K, Cummings S. Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials. Am J Obstet Gynecol 2003; 188: 286–293
- McMahon C G, Abdo C, Incrocci L, et al. Disorders of orgasm and ejaculation in men. J Sex Med 2004; 1: 58–65
- Coker A L. Does physical intimate partner violence affect sexual health? A systematic review. Trauma Violence Abuse 2007; 8: 149–177
- Mulhall J, King R, Glina S, Hvidsten K. Importance of and satisfaction with sex among men and women worldwide: results of the global better sex survey. J Sex Med 2008; 5: 788–795
- Rosen R C, Althof S. Impact of premature ejaculation: the psychological, quality of life, and sexual relationship consequences. J Sex Med 2008; 5: 1296–1307
- Berra M, De Musso F, Armillotta F, et al. The impairment of sexual function stresses menopausal less than premenopausal women. Sexologies 2008; 17: S116
- Gracia C R, Freeman E W, Sammel M D, Lin H, Mogul M. Hormones and sexuality during transition to menopause. Obstet Gynecol 2007; 109: 831–840
- Basson R, Berman J, Burnett A, et al. Report of the International consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 888–894
- Nappi R E. New attitudes to sexuality in the menopause: clinical evaluation and diagnosis. Climacteric 2007; 10: 105–108
- Taylor J E, Rosen R C, Leiblum S R. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women (BISF-W). Arch Sex Behav 1994; 23: 627–643
- Quirk F H, Heiman J, Rosen R, Laane E, Smith M, Boolell M. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med 2002; 11: 331–333
- Rellini A, Meston C. The sensitivity of event logs, self-administered questionnaires and photoplethysmography to detect treatment-induced changes in female sexual arousal disorder (FSAD) diagnosis. J Sex Med 2006; 3: 283–291
- Althof S E, Rosen R C, Derogatis L, Corty E, Quirk F, Symonds T. Outcome measurement in female sexual dysfunction clinical trials: review and recommendations. J Sex Marital Ther 2005; 31: 153–166
- Gastaud F, Bouvattier C, Duranteau L, et al. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 2007; 92: 1391–1396
- Pauls R, Silva W A, Rooney C, et al. Sexual function following anal sphincteroplasty for fecal incontinence. Am J Obstet Gynecol 2007; 197: 618.e1–6
- Smith W, Beadle K, Shuster E J. The impact of a group psychoeducational appointment on women with sexual dysfunction. Am J Obstet Gynecol 2008; 198: 697.e1–6
- Ter Kuile M M, Brauer M, Laan E. The Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS): psychometric properties within a Dutch population. J Sex Marital Ther 2006; 32: 289–304
- Blumel J E, Bravo F, Recavarren M, Sarra S. [Sexual function in postmenopausal women using hormone replacement therapy]. Rev Med Chil 2003; 131: 1251–1255
- Nappi R E, Albani F, Vaccaro P, et al. Use of the Italian translation of the Female Sexual Function Index (FSFI) in routine gynecological practice. Gynecol Endocrinol 2008; 24: 214–219
- Berner M M, Kriston L, Zahradnik H P, Härter M, Rohde A. [Validity and reliability of the German Female sexual Function Index (FSFI-d)]. Geburtshilfe Frauenheilkunde 2004; 64: 293–303
- Blumel J E, Binfa L, Cataldo L, Carrasco A, Izaguirre H, Sarra S. Índice de función sexual femenina: un test para evaluar la sexualidad de la mujer. Rev Chil Obstet Ginecol 2004; 69: 118–125
- Thiel R, Thiel M, Dambros M, et al. [Assessment of female sexual function before and after a procedure for correcting stress urinary incontinence]. Actas Urol Esp 2006; 30: 315–320
- Garcia S, Moreno S, Aponte H. Prevalence of sexual dysfunction in female outpatients and personnel at a Colombian hospital: correlation with hormonal profile. J Sex Med 2008; 5: 1208–1213
- NIH Consensus Conference Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV4th edn. Washington, DC 2000
- CEPAL. Panorama Social de América Latina. CEPAL, Santiago, Chile 2003; 66
- Castelo-Branco C, Blumel J E, Chedraui P, et al. Age at menopause in Latin America. Menopause 2006; 13: 706–712
- Royer M, Castelo-Branco C, Blumel J E, et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 2007; 10: 164–170
- Soules M R, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001; 4: 267–272
- Penteado S R, Fonseca A M, Bagnoli V R, Assis J S, Pinotti J A. Sexuality in healthy postmenopausal women. Climacteric 2003; 6: 321–329
- Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 31: 1–20
- Castelo-Branco C, Blumel J E, et al. Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy. J Obstet Gynaecol 2003; 23: 426–430
- Dennerstein L, Dudley E C, Hopper J L, Burger H. Sexuality, hormones and the menopausal transition. Maturitas 1997; 26: 83–93
- Avis N C, Stellato R, Crawford S, Johannes C. Is there an association between menopause status and sexual functioning. Menopause 2000; 7: 297–309
- Nicolosi A, Laumann E O, Glasser D B, Moreira E D, Jr, Paik A, Gingell C. Global Study of Sexual Attitudes and Behaviors Investigators' Group. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology 2004; 64: 991–997
- Laumann E O, Paik A, Rosen R C. Sexual dysfunction in the United States. Prevalence and predictors. JAMA 1999; 281: 537–544
- González M, Viáfara G, Caba F, Molina E. Sexual function, menopause and hormone replacement therapy (HRT). Maturitas 2004; 48: 411–420
- Castelo-Branco C, Cancelo M J, Chedraui P. Female sexual dysfunction in postmenopausal women. Expert Opinion Therapeutic Patents 2007; 17: 639–647
- McCoy N L. Methodological problems in the study of sexuality and the menopause. Maturitas 1998; 29: 51–60
- Herrera Pérez A, Arriagada Hernández J, González Espinoza C, Leppe Zamora J, Herrera Neira F. [Quality of life and sexual function in postmenopausal women with urinary incontinence]. Actas Urol Esp 2008; 32: 624–628
- Tomic D, Gallicchio L, Whiteman M K, Lewis L M, Langenberg P, Flaws J A. Factors associated with determinants of sexual functioning in midlife women. Maturitas 2006; 53: 144–157
- Mita K, Shigeta M, Kakehashi M, et al. Women's perception of male erectile dysfunction drugs in the general population. Maturitas 2007; 56: 216–222
- Lewis R W, Fugl-Meyer K S, Bosch R, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004; 1: 35–39
- Hayes R D, Dennerstein L, Bennett C M, Fairley C K. What is the ‘true’ prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact. J Sex Med 2008; 5: 777–787
- Levine K B, Williams R E, Hartmann K E. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008; 15: 661–666
- North American Menopause Society's annual meeting, Dallas, Oct. 3–6, 2007. Many menopausal women say vaginal symptoms are a problem. http://www.webmd.com/menopause/news/2007 1005/menopause-symptoms-may-hamper-sex[accessed October 7, 2008]
- Hisasue S, Kumamoto Y, Sato Y, et al. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: a Japanese female cohort study. Urology 2005; 65: 143–148
- Nicolosi A, Moreira E D, Jr, Shirai M, Bin Mohd Tambi M I, Glasser D B. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003; 61: 201–206
- Fisher W A, Rosen R C, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005; 2: 675–684
- Walfisch S, Maoz B, Antonovsky H. Sexual satisfaction among middle-aged couples: correlation with frequency of intercourse and health status. Maturitas 1984; 6: 285–296
- O'Farrell T J, Choquette K A, Cutter H S, Birchler G R. Sexual satisfaction and dysfunction in marriages of male alcoholics: comparison with nonalcoholic maritally conflicted and nonconflicted couples. J Stud Alcohol 1997; 58: 91–99
- Nelson C J. The impact of male sexual dysfunction on the female partner. Current Sexual Health Reports 2006; 3: 37–41
- Spector K R, Boyle M. The prevalence and perceived aetiology of male sexual problems in a non-clinical sample. Br J Med Psychol 1986; 59: 351–358
- Lau J T, Kim J H, Tsui H Y. Mental health and lifestyle correlates of sexual problems and sexual satisfaction in heterosexual Hong Kong Chinese population. Urology 2005; 66: 1271–1281
- Williams K, Reynolds M F. Sexual dysfunction in major depression. CNS Spectr 2006; 11: 19–23
- Delgado P L, Brannan S K, Mallinckrodt C H, et al. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005; 66: 686–692
- Williams V S, Baldwin D S, Hogue S L, Fehnel S E, Hollis K A, Edin H M. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry 2006; 67: 204–210
- West S L, Vinikoor L C, Zolnoun D. A systematic review of the literature on female sexual dysfunction prevalence and predictors. Annu Rev Sex Res 2004; 15: 40–172
- Osvath P, Hekete S, Voros V, Vitra J. Sexual dysfunction among patients treated with antidepressants – a Hungarian retrospective study. Eur Psychiatry 2003; 18: 412–414
- Worthington JJ I II, Peters P M. Treatment of antidepressant-induced sexual dysfunction. Drugs Today 2003; 39: 887–896
- Welton A J, Vickers M R, Kim J, et al. WISDOM team. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ 2008; 337: a1190
- Barnabei V M, Cochrane B B, Aragaki A K, et al. Women's Health Initiative Investigators. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol 2005; 105: 1063–1073
- Keating N L, Clearly P D, Rossi A S, Zaslavsky A M, Ayanian J Z. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999; 130: 545–553